findmyKOL

Daniel Furst, MD

Enriched profile

Professor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles) · Pacific Arthritis Care Center of Los Angeles

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Inglewood, CA · West · United StatesSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1985–2009

Daniel Furst is Professor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles) at Pacific Arthritis Care Center of Los Angeles. OpenAlex indexes 364 publications with 34,660 citations (h-index 82); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory. Clarivate lists Daniel Furst as a Highly Cited Researcher (Clinical Medicine, 2015-2016).

Data verified 14 Aug 2026

Overview

Updated 13 Oct 2026

Daniel E. Furst, MD, is Professor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles). The public record shows 364 publications with 34,660 citations (h-index 82), centered on Rheumatology/Immunology. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 39 companies, 2 NIH-funded awards (1985–2009).

  • Most recent indexed publication: 2026 · Clinical rheumatology
  • Top research focus: Rheumatology/Immunology
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 39 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ST Elevation Myocardial Infarction4 trialsScleroderma, Systemic4 trialsAutoimmune Diseases1 trialIdiopathic Pulmonary Fibrosis1 trialLung Diseases, Interstitial1 trial

Research focus

OpenAlex concept fingerprint
Rheumatology/Immunology

Drugs & molecules

across trials, industry payments and publications
Rinvoqgeneric · UpadacitinibClinical trials—Industry payments53Publications1Acthargeneric · CorticotropinClinical trials—Industry payments6Publications1Xeljanzgeneric · TofacitinibClinical trials—Industry payments47Publications—Remicadegeneric · InfliximabClinical trials—Industry payments35Publications—Tremfyageneric · GuselkumabClinical trials—Industry payments34Publications—SIMPONI ARIAClinical trials—Industry payments32Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments29Publications—Benlystageneric · BelimumabClinical trials—Industry payments23Publications—Opsumitgeneric · MacitentanClinical trials—Industry payments21Publications—Uptravigeneric · SelexipagClinical trials—Industry payments21Publications—NirmatrelvirClinical trials—Industry payments19Publications—Simponigeneric · GolimumabClinical trials—Industry payments18Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments60Janssen Biotech, Inc.Clinical trials—Industry payments52Pfizer Inc.Clinical trials—Industry payments52Amgen Inc.Clinical trials—Industry payments36Novartis Pharmaceuticals CorporationClinical trials—Industry payments29GlaxoSmithKline, LLC.Clinical trials—Industry payments24Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments22Mitsubishi Tanabe Pharma Development America, Inc.Clinical trials—Industry payments22UCB, Inc.Clinical trials—Industry payments19Aurinia Pharma U.S., Inc.Clinical trials—Industry payments14Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments13Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments11Lilly USA, LLCClinical trials—Industry payments10Horizon Therapeutics plcClinical trials—Industry payments6Sobi, IncClinical trials—Industry payments6Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments5Merck Sharp & Dohme LLCClinical trials—Industry payments5United Therapeutics CorporationClinical trials—Industry payments5AstraZeneca Pharmaceuticals LPClinical trials—Industry payments3E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Fresenius Kabi USA, LLCClinical trials—Industry payments3Kyowa Kirin, Inc.Clinical trials—Industry payments3Radius Health, Inc.Clinical trials—Industry payments3National Institute of Allergy and Infectious Diseases (NIAID)Clinical trials2Industry payments—Organon LLCClinical trials—Industry payments2Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments1ANI Pharmaceuticals, Inc.Clinical trials—Industry payments1Biohaven Pharmaceuticals, Inc.Clinical trials—Industry payments1Celltrion USA Inc.Clinical trials—Industry payments1Duke UniversityClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
364publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

34,660citations

Total citations across indexed works.

82h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
39companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1985–2009

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

39 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    29.9%
    Proton pump inhibitor10.5%
    Omeprazole54%Lansoprazole23%Pantoprazole Sodium23%
    Part D<11 patients
    H2 blocker6.9%
    Famotidine100%
    Part D≥21 patients

    + 4 more classes in this area

  • Nervous system

    26.1%
    Gabapentinoids9%
    Gabapentin70%Pregabalin30%
    Part D<11 patients
    Benzodiazepine5.5%
    Alprazolam63%Clonazepam37%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    18.9%
    Statin4.9%
    Rosuvastatin Calcium58%Atorvastatin Calcium42%
    Part D<11 patients
    ACE inhibitor4.5%
    Lisinopril60%Enalapril Maleate40%
    Part D<11 patients

    + 5 more classes in this area

All 10 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 13 Oct 2026

2 NIH research awards on record, funded 1985–2009 per NIH RePORTER. The latest:

Publications

Updated 13 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 13 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/daniel-furst-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Daniel-Furst-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/daniel-furst-19716017a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Daniel-Furst

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    furstrheum.com

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →furstrheum.com ↗
  • Other

    buzzsprout.com/2318677/episodes/15236152-navigating-systemic-sclerosis-signs-symptoms-updates-on-treatment-with-professor-dr-daniel-furst

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗
  • YouTube

    m.youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile: "Professor of Rheumatology, UCLA Health"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Podcast guest

    "Thriving with Arthritis and Autoimmune Diseases" with Dr. Diana Girnita, episode on systemic sclerosis signs, symptoms, and treatment updates

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗
  • Video interview

    EULAR23 conference, interviewed by Dr. Chiara Bellocchi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • Video interview on scleroderma/COVID-19

    "Stream for a Cure" (with Elaine Furst)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • Video

    "Pattern recognition provides clues to rheumatologic diagnoses," Hawaii Dermatology Seminar coverage, MDedge/The Hospitalist

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →blogs.the-hospitalist.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.